BH Labs Knowledge Center

Clinical studies show mild HBOT (1.3–1.5 ATA) improves cognitive function, boosts tissue oxygenation, supports healing, and reduces inflammation—while being safer and more tolerable than high-pressure HBOT. Research in mTBI and chronic brain injury reveals measurable improvements after 40 sessions, with strong safety outcomes and minimal side effects.

A case series of 39 U.S. veterans with mild traumatic brain injury (mTBI) showed a 46.6% average symptom improvement after 40 sessions of HBOT at 1.5 ATA. Brain perfusion improved significantly on SPECT scans, with common benefits including better sleep, mood, and reduced pain—highlighting HBOT as a promising therapy for long-term neurological recovery.

A 2021 clinical trial found that HBOT significantly improved skin quality in older adults, increasing collagen density (p < 0.001), elastic fiber length (p < 0.0001), and blood vessel formation. It also reduced senescent cell counts, suggesting HBOT may reverse skin aging at a cellular level—offering clinics a science-backed, noninvasive approach to aesthetic and regenerative care.

Peer-reviewed study shows HBOT before abdominoplasty surgery can reduce post-op complications by 74%. No cases of tissue necrosis occurred in the HBOT group, while the control group had a 6.2% necrosis rate. HBOT was confirmed as an independent protective factor, suggesting it may enhance surgical outcomes in aesthetic procedures like tummy tucks.

Case–control study shows HBOT can accelerate facelift recovery by 64%, reducing wound healing time from 36.9 to 13.3 days. Patients receiving HBOT had faster healing, fewer complications, and higher satisfaction—highlighting HBOT as a valuable adjunct for aesthetic surgery recovery protocols.